YU238259 Is a Novel Inhibitor of Homology-Dependent DNA Repair That Exhibits Synthetic Lethality and Radiosensitization in Repair-Deficient Tumors
Gregory C. Stachelek(Yale University), Peter M. Glazer(Yale University), Jack M. Qian(South Shore Hospital), Laura Abriola(University of New Haven), Luke Pike(Memorial Sloan Kettering Cancer Center), Janie Merkel(University of New Haven), Rafael Fernández(Yale University), Elizabeth Peterson-Roth(Yale University), Yanfeng Liu(Shanghai Jiao Tong University), William Hungerford(University of New Haven)
Cited by 20
Related Papers
The Role of ATF4 Stabilization and Autophagy in Resistance of Breast Cancer Cells Treated with Bortezomib
|Cancer Research|2009|298
Large language models to identify social determinants of health in electronic health records
|npj Digital Medicine|2024|275
TRIM25 promotes the cell survival and growth of hepatocellular carcinoma through targeting Keap1-Nrf2 pathway
|Nature Communications|2020|273
Timing and type of immune checkpoint therapy affect the early radiographic response of melanoma brain metastases to stereotactic radiosurgery
|Cancer|2016|211
Molecular and Cellular Pharmacology of the Hypoxia-Activated Prodrug TH-302
|Molecular Cancer Therapeutics|2011|206